| TVTXTravere Therapeutics, Inc. | Sep 17, 20269:35 PM ET | Sep 15 – Sep 16, 2026 | ROTE WILLIAM E.Chief Research Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −209.05K | $62.8344 | −$13.14M | 98.2K | −68.0% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | May 6, 2026 | May 6, 2026 | ROTE WILLIAM E.Chief Research Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.76K | $43.95 | −$121.43K | 115.47K | −2.3% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Apr 23, 2026 | Apr 22, 2026 | ROTE WILLIAM E.Chief Research Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −9.1K | $39.09 | −$355.72K | 113.99K | −7.4% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 3, 2026 | Feb 3, 2026 | ROTE WILLIAM E.Chief Research Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −12.45K | $32.87 | −$409.1K | 109.09K | −10.2% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Dec 29, 2025 | Dec 24, 2025 | ROTE WILLIAM E.Chief Research Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −60K | $40.10 | −$2.41M | 101.44K | −37.2% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | May 5, 2025 | May 5, 2025 | ROTE WILLIAM E.Chief Research Officer | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −3.2K | $21.05 | −$67.32K | 100.24K | −3.1% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 12, 2025 | Feb 12, 2025 | ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −5.2K | $23.53 | −$122.36K | 98.52K | −5.0% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 4, 2025 | Feb 3, 2025 | ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −8.95K | $19.78 | −$177.05K | 95.72K | −8.6% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Jan 23, 2025 | Jan 22, 2025 | ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.44K | $19.46 | −$47.42K | 83.17K | −2.8% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Sep 9, 2024 | Sep 9, 2024 | ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −4.39K | $11.52 | −$50.54K | 84.46K | −4.9% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 2, 2024 | Feb 1, 2024 | ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −4.76K | $8.7094 | −$41.49K | 80.72K | −5.6% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Jan 25, 2024 | Jan 23, 2024 | ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.06K | $8.96 | −$18.48K | 60.48K | −3.3% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Sep 5, 2023 | Sep 5, 2023 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −1.82K | $14.71 | −$26.7K | 61.17K | −2.9% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | May 12, 2023 | May 10, 2023 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −825 | $16.59 | −$13.69K | 59.21K | −1.4% | SEC↗10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| TVTXTravere Therapeutics, Inc. | Feb 2, 2023 | Feb 1, 2023 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.59K | $22.25 | −$57.63K | 60.04K | −4.1% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Jan 26, 2023 | Jan 24, 2023 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.06K | $21.50 | −$44.33K | 42.38K | −4.6% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | May 12, 2022 | May 11, 2022 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −1.56K | $21.7167 | −$33.94K | 43.67K | −3.5% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Feb 2, 2022 | Jan 31, 2022 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −1.13K | $27.40 | −$30.83K | 45.24K | −2.4% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Jan 26, 2022 | Jan 24, 2022 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −1.88K | $24.98 | −$46.84K | 36.52K | −4.9% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Jan 12, 2022 | Jan 11, 2022 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −2.5K | $27.40 | −$68.5K | 38.4K | −6.1% | SEC↗ |
| TVTXTravere Therapeutics, Inc. | Aug 17, 2021 | Aug 17, 2021 | ROTE WILLIAM E.Senior Vice President, R&D | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase.Common Stock | −1.41K | $17.12 | −$24.09K | 35.73K | −3.8% | SEC↗ |
